Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Adenosine Triphosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 known ✓ | P47900 | 8/20 | 0.78 |
| ▸ | P2RY2 known ✓ | P41231 | 4/20 | 0.78 |
| ▸ | ADORA1 known ✓ | P30542 | 1/20 | 0.78 |
| ▸ | PDE4D known ✓ | Q08499 | 1/20 | 0.78 |
| ▸ | PDE3A known ✓ | Q14432 | 1/20 | 0.78 |
| ▸ | P2RX1 | P51575 | 3/20 | 0.78 |
| ▸ | P2RX3 | P56373 | 3/20 | 0.78 |
| ▸ | SRC | P12931 | 2/20 | 0.78 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.78 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.78 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.78 |
| ▸ | P2RY11 | Q96G91 | 2/20 | 0.78 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.78 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.78 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.78 |
| ▸ | LDHA | P00338 | 1/20 | 0.78 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.78 |
| ▸ | FBP1 | P09467 | 1/20 | 0.78 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenosine Triphosphate SCHEMBL30185881 | 1.00 | P2RY1 (0.78) | P2RY1P2RY2P2RX1P2RX3SRC | |
| Adenosine Triphosphate SCHEMBL2960692 | 0.98 | P2RY1 (0.78) | P2RY1P2RY2P2RX1P2RX3SRC | |
| Adenosine Triphosphate SCHEMBL31091233 | 0.97 | P2RY1 (0.77) | P2RY1P2RY2P2RX1P2RX3SRC | |
| Adenosine Triphosphate SCHEMBL29653413 | 0.97 | P2RY1 (0.77) | P2RY1P2RY2P2RX1P2RX3SRC | |
| Adenosine Triphosphate SCHEMBL8852600 | 0.97 | P2RY1 (0.77) | P2RY1P2RY2P2RX1P2RX3SRC | |
| Adenosine Diphosphate SCHEMBL5498278 | 0.96 | P2RY1 (0.80) | P2RY1P2RY2P2RX1P2RX3SRC | |
| Adenosine Triphosphate SCHEMBL29352529 | 0.95 | P2RY1 (0.78) | P2RY1P2RY2P2RX1P2RX3SRC | |
| Adenosine Triphosphate SCHEMBL28359 | 0.95 | P2RY1 (0.78) | P2RY1P2RY2P2RX1P2RX3SRC | |
| Adenosine Triphosphate SCHEMBL28357 | 0.95 | P2RY1 (0.78) | P2RY1P2RY2P2RX1P2RX3SRC | |
| Adenosine Diphosphate SCHEMBL4406439 | 0.95 | P2RY1 (0.80) | P2RY1P2RY2P2RX1P2RX3SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117467715-A | Process for simultaneously preparing D-glutamic acid and L-glutathione by multi-step enzyme method | 珠海瑞德林生物有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-116410938-B | Beta-alanine ligase mutant and application thereof | 深圳瑞德林生物技术有限公司 | 2024-03-12 | — | — | CN | disclosed |
| CN-117467715-A | Process for simultaneously preparing D-glutamic acid and L-glutathione by multi-step enzyme method | 珠海瑞德林生物有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-117384991-A | Preparation method and application of high-bioactivity cyclic peptide | 上海中翊日化有限公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-113584105-B | Method for preparing puromycin by enzyme method | 深圳瑞德林生物技术有限公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-116445429-A | Beta-alanine ligase mutant and application thereof | 深圳瑞德林生物技术有限公司 | 2023-07-18 | — | — | CN | disclosed |
| CN-116410938-A | Beta-alanine ligase mutant and application thereof | 深圳瑞德林生物技术有限公司 | 2023-07-11 | — | — | CN | disclosed |
| CN-116376853-A | Beta-alanine ligase mutant and application thereof | 深圳瑞德林生物技术有限公司 | 2023-07-04 | — | — | CN | disclosed |
| CN-115992103-A | Enzyme mutant and preparation method of snake venom tripeptide | 深圳瑞德林生物技术有限公司 | 2023-04-21 | — | — | CN | disclosed |
| CN-115820574-A | Leucine ligase mutant and application thereof | 深圳瑞德林生物技术有限公司 | 2023-03-21 | — | — | CN | disclosed |
| CN-115820578-A | Mutant composition, fusion enzyme and preparation method of collagen tripeptide | 深圳瑞德林生物技术有限公司 | 2023-03-21 | — | — | CN | disclosed |
| CN-115806946-A | Preparation method of kyotorphin and derivatives thereof | 深圳瑞德林生物技术有限公司 | 2023-03-17 | — | — | CN | disclosed |
| EP-2301555-B1 | CREAMY O/W EMULSION COMPOSITION AND PRODUCTION PROCESS THEREOF | OTSUKA PHARMA CO LTD (JP) | 2016-02-17 | — | — | EP | disclosed |
| US-8492360-B2 | Creamy O/W emulsion composition and production process thereof | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-07-23 | — | — | US | disclosed |
| US-20110112045-A1 | CREAMY O/W EMULSION COMPOSITION AND PRODUCTION PROCESS THEREOF | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2011-05-12 | — | — | US | disclosed |
| EP-2301555-A1 | CREAM-LIKE O/W TYPE EMULSIFIED COMPOSITION AND METHOD FOR PRODUCING SAME | Otsuka Pharmaceutical Co., Ltd. (JP) | 2011-03-30 | — | — | EP | disclosed |
| EP-1342462-B1 | O/W EMULSION COMPOSITION AND METHOD OF PREPARING THE SAME | OTSUKA PHARMA CO LTD (JP) | 2007-04-11 | — | — | EP | disclosed |
| US-6946436-B2 | O/W emulsion composition and method of preparing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-09-20 | — | — | US | disclosed |
| US-20040029761-A1 | O/W emulsion composition and method of preparing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2004-02-12 | — | — | US | disclosed |
| EP-1342462-A1 | O/W EMULSION COMPOSITION AND METHOD OF PREPARING THE SAME | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2003-09-10 | — | — | EP | disclosed |